Literature DB >> 27107105

Reply to "Are the TR46/Y121F/T289A Mutations in Azole-Resistant Aspergillosis Patient Acquired or Environmental?".

Jose A Vazquez1, Elias K Manavathu2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27107105      PMCID： PMC4862489          DOI： 10.1128/AAC.00380-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  5 in total

1.  Are the TR46/Y121F/T289A Mutations in Azole-Resistant Aspergillosis Patient Acquired or Environmental?

Authors:  Jochem B Buil; Jacques F Meis; Willem J G Melchers; Paul E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

2.  Molecular Characterization of a Voriconazole-Resistant, Posaconazole-Susceptible Aspergillus fumigatus Isolate in a Lung Transplant Recipient in the United States.

Authors:  Jose A Vazquez; Elias K Manavathu
Journal:  Antimicrob Agents Chemother       Date:  2015-11-16       Impact factor: 5.191

3.  Characterization of multiple isolates of Aspergillus fumigatus from patients: genotype, mating type and invasiveness.

Authors:  Sergio Alvarez-Perez; Marta E Garcia; Emilio Bouza; Teresa Pelaez; Jose L Blanco
Journal:  Med Mycol       Date:  2009       Impact factor: 4.076

4.  First Detection of TR34 L98H and TR46 Y121F T289A Cyp51 Mutations in Aspergillus fumigatus Isolates in the United States.

Authors:  Nathan P Wiederhold; Veronica Garcia Gil; Felipe Gutierrez; Jonathan R Lindner; Mohammad T Albataineh; Dora I McCarthy; Carmita Sanders; Hongxin Fan; Annette W Fothergill; Deanna A Sutton
Journal:  J Clin Microbiol       Date:  2015-10-21       Impact factor: 5.948

5.  Passive surveillance for azole-resistant Aspergillus fumigatus, United States, 2011-2013.

Authors:  Cau D Pham; Errol Reiss; Ferry Hagen; Jacques F Meis; Shawn R Lockhart
Journal:  Emerg Infect Dis       Date:  2014-09       Impact factor: 6.883
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.